Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway–mediated disorders
Article in Frontiers in Immunology (November 2023)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (November 2023)
Article in Veterinary Sciences (September 2023)
Article in Frontiers in Cellular and Infection Microbiology (July 2022)